PDE4 inhibitors

2017-08-01T17:55:01+03:00[Europe/Moscow] en true Filaminast, Rolipram, Propentofylline, Phosphodiesterase-4 inhibitor, Apremilast, Etazolate, Mesembrenone, Luteolin, Drotaverine, Glaucine, Ibudilast, Piclamilast, RPL-554, Roflumilast, Mesembrine, Pentoxifylline, Cilomilast, Crisaborole flashcards PDE4 inhibitors
Click to flip
  • Filaminast
    Filaminast (WAY-PDA 641) was a drug candidate developed by Wyeth-Ayerst.
  • Rolipram
    Rolipram is a selective phosphodiesterase-4 inhibitor discovered and developed by Schering AG as a potential antidepressant drug in the early 1990s.
  • Propentofylline
    Propentofylline (HWA 285) is a xanthine derivative with purported neuroprotective effects.
  • Phosphodiesterase-4 inhibitor
    A phosphodiesterase type 4 inhibitor, commonly referred to as a PDE4 inhibitor, is a drug used to block the degradative action of phosphodiesterase 4 (PDE4) on cyclic adenosine monophosphate (cAMP).
  • Apremilast
    Apremilast (brand name Otezla, by Celgene) is a drug for the treatment of certain types of psoriasis and psoriatic arthritis.
  • Etazolate
    Etazolate (SQ-20,009, EHT-0202) is an anxiolytic drug which is a pyrazolopyridine derivative and has unique pharmacological properties.
  • Mesembrenone
    Mesembrenone is an alkaloid constituent of Sceletium tortuosum (Kanna).
  • Luteolin
    Luteolin is a flavone, a type of flavonoid.
  • Drotaverine
    Drotaverine (INN, also known as drotaverin) is an antispasmodic drug, used to enhance cervical dilation during childbirth.
  • Glaucine
    Glaucine is an alkaloid found in several different plant species in the Papaveraceae family such as Glaucium flavum, Glaucium oxylobum and Corydalis yanhusuo, and in other plants like Croton lechleri in the family Euphorbiaceae.
  • Ibudilast
    Ibudilast (development codes: AV-411 or MN-166) is an anti-inflammatory drug used mainly in Japan, which acts as a phosphodiesterase inhibitor, inhibiting the PDE4 subtype to the greatest extent, but also showing significant inhibition of other PDE subtypes.
  • Piclamilast
    Piclamilast (RP 73401), is a selective PDE4 inhibitor.
  • RPL-554
    RPL-554 (LS-193,855) is a drug candidate for respiratory diseases.
  • Roflumilast
    Roflumilast (trade names Daxas, Daliresp) is a drug that acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4).
  • Mesembrine
    Mesembrine is an alkaloid present in Sceletium tortuosum (kanna).
  • Pentoxifylline
    Pentoxifylline (INN, BAN, USAN) or oxpentifylline (AAN) is a is a xanthine derivative used as a drug to treat muscle pain in people with peripheral artery disease.
  • Cilomilast
    Cilomilast (INN, codenamed SB-207,499, proposed trade name Ariflo) is a drug which was developed for the treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD).
  • Crisaborole
    Crisaborole (INN, USAN, codenamed AN2728) is a non-steroidal, topical drug candidate that as of 2015 was under development by Anacor Pharmaceuticals for the topical treatment of psoriasis and atopic dermatitis (atopic eczema).